Advertisement

Analgesic Placebo Treatment Perceptions: Acceptability, Efficacy, and Knowledge

  • Nkaku R. Kisaalita
    Affiliations
    Center for Pain Research and Behavioral Health, Department of Clinical and Health Psychology, University of Florida, Gainesville, Florida
    Search for articles by this author
  • Michael E. Robinson
    Correspondence
    Address reprint requests to Michael E. Robinson, Center for Pain Research and Behavioral Health, Department of Clinical and Health Psychology, University of Florida, PO Box 100165, Gainesville, FL 32610-0165.
    Affiliations
    Center for Pain Research and Behavioral Health, Department of Clinical and Health Psychology, University of Florida, Gainesville, Florida
    Search for articles by this author
Published:August 02, 2012DOI:https://doi.org/10.1016/j.jpain.2012.06.003

      Abstract

      Current evidence supports the efficacy of placebo analgesia and illustrates that patients may be open to placebo use despite uncertainty regarding its mechanisms. Debate persists, however, concerning the ethics of placebo treatments. The purpose of the present web-based study was to expand upon the empirical literature on placebo analgesia ethics and acceptability. Participants (n = 100) provided their definition of a placebo and responded to 24 questions addressing placebo analgesia perceived knowledge, acceptability, effectiveness, and likelihood of placebo use among different health care providers. Results support previous research on the effects of placebo on negative mood and health care provider attributions, with findings illustrating that negative consequences of administration were largely mitigated by a beneficial treatment outcome. Results showed that participants conceptualized placebo as predominately inert and were mixed regarding interpretations of placebo effectiveness. Though acceptability ratings were dependent on the context of placebo administration, participants endorsing even moderate placebo acceptability were more open to placebo interventions and reported overall more positive treatment outcomes. Participants believed that placebos were used differentially among health care providers. Additional studies are needed to determine if placebo education can beneficially impact perceptions of placebo analgesia knowledge, acceptability, and treatment effectiveness.

      Perspective

      This study presents an examination of analgesic placebo treatment perceived acceptability, efficacy, and knowledge among lay individuals. Our findings highlight the importance of assessing placebo conceptualizations and treatment perceptions in evaluating placebo ethics—a highly relevant finding that informs the clinical use of placebo components in managing pain.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The Journal of Pain
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Amanzio M.
        • Benedetti F.
        Neuropharmacological dissection of placebo analgesia: Expectation-activated opioid systems versus conditioning-activated specific subsystems.
        J Neurosci. 1999; 19: 484-494
        • Amanzio M.
        • Pollo A.
        • Maggi G.
        • Benedetti F.
        Response variability to analgesics: A role for non-specific activation of endogenous opioids.
        Pain. 2001; 90: 205-215
        • Benedetti F.
        The opposite effects of the opiate antagonist naloxone and the cholecystokinin antagonist proglumide on placebo analgesia.
        Pain. 1996; 64: 535-543
        • Benedetti F.
        • Pollo A.
        • Colloca L.
        Opioid-mediated placebo responses boost pain endurance and physical performance: Is it doping in sport competitions?.
        J Neurosci. 2007; 27: 11934-11939
        • Cacioppo J.T.
        • Berntson G.G.
        Relationship between attitudes and evaluative space: A critical review, with emphasis on the separability of positive and negative substrates.
        Psychol Bull. 1994; 115: 401-423
        • Chen G.-F.
        • Johnson M.
        Patients' attitudes to the use of placebos: Results from a New Zealand survey.
        N Z Med J. 2009; 122: 11
        • Chung S.K.
        • Price D.D.
        • Verne G.N.
        • Robinson M.E.
        Revelation of a personal placebo response: Its effects on mood, attitudes and future placebo responding.
        Pain. 2007; 132: 281-288
        • Colloca L.
        • Lopiano L.
        • Lanotte M.
        • Benedetti F.
        Overt versus covert treatment for pain, anxiety, and Parkinson's disease.
        Lancet Neurol. 2004; 3: 679-684
        • Cupples B.
        • Myron G.
        The investigator's duty not to deceive.
        IRB. 1985; 7: 1-6
        • Fassler M.
        • Gnadinger M.
        • Rosemann T.
        • Biller-Andorno N.
        Placebo interventions in practice: A questionnaire survey on the attitudes of patients and physicians.
        Br J Gen Pract. 2011; 61: 101-107
        • Fassler M.
        • Gnadinger M.
        • Rosemann T.
        • Biller-Andorno N.
        Use of placebo interventions among Swiss primary care providers.
        BMC Health Servi Res. 2009; 9: 144
        • Fassler M.
        • Meissner K.
        • Schneider A.
        • Linde K.
        Frequency and circumstances of placebo use in clinical practice - a systematic review of empirical studies.
        BMC Med. 2010; 8: 15
        • Finniss D.G.
        • Kaptchuk T.J.
        • Miller F.
        • Benedetti F.
        Biological, clinical, and ethical advances of placebo effects.
        Lancet. 2010; 375: 686-695
        • Goodwin J.S.
        • Goodwin J.M.
        • Vogel A.V.
        Knowledge and use of placebos by house officers and nurses.
        Ann Intern Med. 1979; 91: 106-110
        • Gray G.
        • Flynn P.
        A survey of placebo use in a general hospital.
        Gen Hosp Psychiatry. 1981; 3: 199-203
        • Hing E.
        • Cherry D.K.
        • Woodwell D.A.
        National Ambulatory Medical Care Survey: 2004 summary.
        Adv Data. 2006; 23: 1-33
        • Hirsh A.T.
        • Waxenberg L.B.
        • Atchison J.W.
        • Gremillion H.A.
        • Robinson M.E.
        Evidence for sex differences in the relationships of pain, mood, and disability.
        J Pain. 2006; 7: 592-601
        • Hróbjartsson A.
        • Gøtzsche P.C.
        Is the placebo powerless? Update of a systematic review with 52 new randomized trials comparing placebo with no treatment.
        J Intern Med. 2004; 256: 91-100
        • Hróbjartsson A.
        • Gøtzsche Peter C.
        Placebo interventions for all clinical conditions. Cochrane Database of Systematic Reviews.
        John Wiley & Sons, Ltd, Chichester, UK2010
        • Hrobjartsson A.
        • Norup M.
        The use of placebo interventions in medical practice–a national questionnaire survey of Danish clinicians.
        Eval Health Prof. 2003; 26: 153-165
        • Jonas W.B.
        Reframing placebo in research and practice.
        Philos Trans R Soc B Biol Sci. 2011; 366: 1896-1904
        • Kaptchuk T.J.
        Powerful placebo: The dark side of the randomised controlled trial.
        Lancet. 1998; 351: 1722-1725
        • Kaptchuk T.J.
        • Friedlander E.
        • Kelley J.M.
        • Sanchez M.N.
        • Kokkotou E.
        • Singer J.P.
        • Kowalczykowski M.
        • Miller F.G.
        • Kirsch I.
        • Lembo A.J.
        Placebos without deception: A randomized controlled trial in irritable bowel syndrome.
        PLoS ONE. 2010; 5: e15591
        • Kisaalita N.R.
        • Roditi D.
        • Robinson M.E.
        Factors affecting placebo acceptability: Deception, outcome, and disease severity.
        J Pain. 2011; 12: 920-928
        • Landis J.R.
        • Koch G.G.
        The measurement of observer agreement for categorical data.
        Biometrics. 1977; 33: 159-174
        • Levine J.D.
        • Gordon N.C.
        • Smith R.
        • Fields H.L.
        Analgesic responses to morphine and placebo in individuals with postoperative pain.
        Pain. 1981; 10: 379-389
        • Lynöe N.
        • Mattsson B.
        • Sandlund M.
        The attitudes of patients and physicians towards placebo treatment–a comparative study.
        Soc Sci Med. 1993; 36: 767-774
        • Meissner K.
        • Höfner L.
        • Fässler M.
        • Linde K.
        Widespread use of pure and impure placebo interventions by GPs in Germany.
        Fam Pract. 2011; 29: 79-85
        • Miller F.G.
        • Colloca L.
        The legitimacy of placebo treatments in clinical practice: Evidence and ethics.
        Am J Bioeth. 2009; 9: 39-47
        • Miller F.G.
        • Wendler D.
        • Swartzman L.C.
        Deception in research on the placebo effect.
        PLoS Medicine. 2005; 2: 853-858
        • Pollo A.
        • Carlino E.
        • Benedetti F.
        The top-down influence of ergogenic placebos on muscle work and fatigue.
        Eur J Neurosci. 2008; 28: 379-388
        • Price D.D.
        • Craggs J.
        • Nicholas Verne G.
        • Perlstein W.M.
        • Robinson M.E.
        Placebo analgesia is accompanied by large reductions in pain-related brain activity in irritable bowel syndrome patients.
        Pain. 2007; 127: 63-72
        • Price D.D.
        • Finniss D.G.
        • Benedetti F.
        A comprehensive review of the placebo effect: Recent advances and current thoughts.
        Annu Rev Psychol. 2008; 59: 2.1-2.26
        • Robinson M.E.
        • Riley III, J.L.
        • Gatchel R.J.
        • Turk D.C.
        The role of emotion in pain.
        Guilford Press, New York, NY1999 (pp 74–88)
        • Sackett P.R.
        • Laczo R.M.
        • Arvey R.D.
        The effects of range restriction on estimates of criterion interrater reliability: Implications for validation research.
        Personnel Psychol. 2002; 55: 807-825
        • Sullivan M.
        • Terman G.W.
        • Peck B.
        • Correll D.J.
        • Rich B.
        • Clark W.C.
        • Latta K.
        • Lebovits A.
        • Gebhart G.
        APS position statement on the use of placebos in pain management.
        J Pain. 2005; 6: 215-217
        • Tilburt J.C.
        • Emanuel E.J.
        • Kaptchuk T.J.
        • Curlin F.A.
        • Miller F.G.
        Prescribing placebo treatments: Results of national survey of US internists and rheumatologists.
        BMJ. 2008; : 337
        • Vase L.
        • Petersen G.T.
        • Riley J.L.
        • Price D.
        Factors contributing to large analgesic effects in placebo mechanism studies conducted between 2002 and 2007.
        Pain. 2009; 145: 36-44
        • Vase L.
        • Riley J.L.
        • Price D.D.
        A comparison of placebo effects in clinical analgesic trials versus studies of placebo analgesia.
        Pain. 2002; 99: 443-452
        • Vase L.
        • Robinson M.E.
        • Verne G.N.
        • Price D.D.
        The contributions of suggestion, desire, and expectation to placebo effects in irritable bowel syndrome patients: An empirical investigation.
        Pain. 2003; 105: 17-25
        • Vase L.
        • Robinson M.E.
        • Verne G.N.
        • Price D.D.
        Increased placebo analgesia over time in irritable bowel syndrome (IBS) patients is associated with desire and expectation but not endogenous opioid mechanisms.
        Pain. 2005; 115: 338-347
        • Watson D.
        • Clark L.A.
        Measurement and mismeasurement of mood: Recurrent and emergent issues.
        J Pers Assess. 1997; 68: 267-296
        • Watson D.
        • Tellegen A.
        Toward a consensual structure of mood.
        Psychol Bull. 1985; 98: 219-235